Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program

BACKGROUND: Evolving mutations of the novel coronavirus continue to fuel up the pandemic. The virus affects the human respiratory system along with other body systems, causing several sequelae in the survivors of the disease, presented as post-COVID-19 syndrome or long-COVID-19. This protocol utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Vij, Ridhima, Kim, Hosu, Park, Hyeonggeun, Cheng, Thanh, Lotfi, Djamchid, Chang, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557203/
https://www.ncbi.nlm.nih.gov/pubmed/37798650
http://dx.doi.org/10.1186/s13287-023-03522-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557203/
https://www.ncbi.nlm.nih.gov/pubmed/37798650
http://dx.doi.org/10.1186/s13287-023-03522-1

Ejemplares similares